Benralizumab Promising for Rhinosinusitis With Nasal Polyps
Benralizumab (Fasenra) significantly reduced nasal polyp score (NPS) and average nasal blockage score (NBS) compared with placebo for patients with
Read moreBenralizumab (Fasenra) significantly reduced nasal polyp score (NPS) and average nasal blockage score (NBS) compared with placebo for patients with
Read moreEditor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Physician compensation plummeted in the opening
Read moreNEW YORK (Reuters Health) – People with sinonasal inflammation show decreased functional brain connectivity, according to a small proof-of-concept study.
Read more(Reuters) – Diagnosed with asthma at 8 years old, Karlaine Francisco grew up thinking everyone had it. Her friends in
Read moreThe US Food and Drug Administration (FDA) has approved a new, once-daily oral stimulant medication for treatment of attention deficit
Read moreNEW YORK (Reuters Health) – Dupilumab, a monoclonal antibody targeting interleukin-4 (IL-4) receptor alpha, should be considered in patients with
Read morePeople who have had major sinus surgery should consult their ENT doctor before undergoing COVID-19 swab testing, new research indicates.
Read moreAn implanted device is showing promise in patients with bilateral vestibular hypofunction (BVH), a debilitating condition that significantly impairs balance.
Read more